L2 Asset Management, LLC Bristol Myers Squibb CO Transaction History
L2 Asset Management, LLC
- $326 Million
- Q2 2024
A detailed history of L2 Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, L2 Asset Management, LLC holds 14,713 shares of BMY stock, worth $823,192. This represents 0.19% of its overall portfolio holdings.
Number of Shares
14,713
Previous 6,285
134.1%
Holding current value
$823,192
Previous $340,000
79.71%
% of portfolio
0.19%
Previous 0.11%
Shares
15 transactions
Others Institutions Holding BMY
# of Institutions
2,454Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.4 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.12 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.18 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.3 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...